Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arterial pressure after transplantation]

D Farge1, J Julien

  • 1Hôpital Saint-Louis, service de médecine interne du Pr Rouffy, Paris.

La Revue Du Praticien
|February 15, 1994
PubMed
Summary

Cyclosporine use after organ transplantation frequently causes new-onset arterial hypertension, primarily diastolic. Early detection and treatment with specific antihypertensive drugs are crucial for graft function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?

La Revue de medecine interne·2024
Same author

French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases.

La Revue de medecine interne·2024
Same author

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II.

Frontiers in immunology·2022
Same author

The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.

Journal de medecine vasculaire·2022
Same author

Long-term use of tinzaparin for the treatment of cancer-associated thrombosis in clinical practice: Insights from the prospective TROPIQUE study.

Journal de medecine vasculaire·2022
Same author

Patient education program at the forefront of cancer-associated thrombosis care.

Journal de medecine vasculaire·2021

Area of Science:

  • Nephrology
  • Pharmacology
  • Cardiology

Context:

  • Arterial hypertension is a common complication post-organ transplantation.
  • Cyclosporine, a common immunosuppressant, is a major cause of de novo hypertension.
  • Hypertension significantly impacts graft survival and function.

Purpose:

  • To describe the incidence, mechanisms, and management of de novo arterial hypertension following organ transplantation.
  • To highlight the role of cyclosporine in drug-induced hypertension.
  • To provide guidance on therapeutic strategies for post-transplant hypertension.

Summary:

  • De novo arterial hypertension occurs in over two-thirds of organ transplant recipients within the first year, largely due to cyclosporine.
  • This hypertension, often diastolic, results from cyclosporine's nephrotoxicity and vasoconstrictive effects, involving the renin-angiotensin and sympathetic systems.
  • Management involves arteriole-dilating agents like calcium channel blockers or ACE inhibitors, with other classes used for severe cases.

Impact:

  • Early detection and management of cyclosporine-induced hypertension are vital for preserving organ graft function.
  • Understanding the mechanisms aids in developing targeted therapeutic approaches.
  • This research contributes to optimizing long-term outcomes for organ transplant recipients.

Related Experiment Videos